NM_001498.4:c.1198-59T>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001498.4(GCLC):​c.1198-59T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 920,932 control chromosomes in the GnomAD database, including 19,115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.19 ( 4576 hom., cov: 32)
Exomes 𝑓: 0.13 ( 14539 hom. )

Consequence

GCLC
NM_001498.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.80

Publications

6 publications found
Variant links:
Genes affected
GCLC (HGNC:4311): (glutamate-cysteine ligase catalytic subunit) Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct 2010]
GCLC-AS1 (HGNC:56649): (GCLC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 6-53505954-A-T is Benign according to our data. Variant chr6-53505954-A-T is described in ClinVar as Benign. ClinVar VariationId is 1251336.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.421 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GCLCNM_001498.4 linkc.1198-59T>A intron_variant Intron 10 of 15 ENST00000650454.1 NP_001489.1 P48506Q14TF0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GCLCENST00000650454.1 linkc.1198-59T>A intron_variant Intron 10 of 15 NM_001498.4 ENSP00000497574.1 P48506

Frequencies

GnomAD3 genomes
AF:
0.192
AC:
29194
AN:
152042
Hom.:
4554
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.357
Gnomad AMI
AF:
0.107
Gnomad AMR
AF:
0.349
Gnomad ASJ
AF:
0.0639
Gnomad EAS
AF:
0.436
Gnomad SAS
AF:
0.225
Gnomad FIN
AF:
0.0956
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.0596
Gnomad OTH
AF:
0.161
GnomAD4 exome
AF:
0.133
AC:
102023
AN:
768772
Hom.:
14539
Cov.:
10
AF XY:
0.130
AC XY:
53268
AN XY:
410038
show subpopulations
African (AFR)
AF:
0.368
AC:
7505
AN:
20374
American (AMR)
AF:
0.497
AC:
21757
AN:
43788
Ashkenazi Jewish (ASJ)
AF:
0.0754
AC:
1647
AN:
21832
East Asian (EAS)
AF:
0.450
AC:
16462
AN:
36568
South Asian (SAS)
AF:
0.208
AC:
15048
AN:
72442
European-Finnish (FIN)
AF:
0.0968
AC:
5117
AN:
52852
Middle Eastern (MID)
AF:
0.143
AC:
621
AN:
4352
European-Non Finnish (NFE)
AF:
0.0597
AC:
28589
AN:
478838
Other (OTH)
AF:
0.140
AC:
5277
AN:
37726
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4355
8710
13066
17421
21776
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1018
2036
3054
4072
5090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.192
AC:
29276
AN:
152160
Hom.:
4576
Cov.:
32
AF XY:
0.199
AC XY:
14817
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.357
AC:
14806
AN:
41476
American (AMR)
AF:
0.349
AC:
5339
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0639
AC:
222
AN:
3472
East Asian (EAS)
AF:
0.436
AC:
2257
AN:
5172
South Asian (SAS)
AF:
0.227
AC:
1093
AN:
4820
European-Finnish (FIN)
AF:
0.0956
AC:
1014
AN:
10602
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.0596
AC:
4052
AN:
68018
Other (OTH)
AF:
0.166
AC:
351
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1020
2040
3059
4079
5099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
347
Bravo
AF:
0.222
Asia WGS
AF:
0.310
AC:
1075
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.0
DANN
Benign
0.71
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1014852; hg19: chr6-53370752; API